Walker, I., Panzarella, T., Couban, S., Couture, F., Devins, G., Elemary, M., Gallagher, G., Kerr, H., Kuruvilla, J., Lee, S. J., Moore, J., Nevill, T., Popradi, G., Roy, J., Schultz, K. R., Szwajcer, D., Toze, C., Foley, R., & , (2020). addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial. Lancet, 7(2), e100–e111. http://access.bl.uk/ark:/81055/vdc_100099424602.0x000005